Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Xth Eurasian Hematology-Oncology Congress
M

Primary and Nodal Tumor Factors Warranting Postoperative Adjuvant Treatment and Timing of Therapy of Head&Neck Cancer

By Xth Eurasian Hematology-Oncology Congress FEATURING Musa Altun
By Xth Eurasian Hematology-Oncology Congress FEATURING Musa Altun
32 views
November 12, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
Head & Neck
13:20

2019 Update on HPV+ Oropharyngeal Cancer: New 8th Edition Staging Gi…

Xth Eurasian Hematology-Oncology Congress

K. Toraman

16 views
13:48

New 8th Edition Staging in HPV+ Oropharyngeal Cancer: De-Escalation …

Xth Eurasian Hematology-Oncology Congress

K. Toraman

26 views
32:46

Surgical Options for p16-Negative Advanced Head and Neck Cancer

Xth Eurasian Hematology-Oncology Congress

B. Basaran

88 views
12:53

Primary and Nodal Tumor Factors Warranting Postoperative Adjuvant Tr…

Xth Eurasian Hematology-Oncology Congress

M. Altun

32 views
08:59

Postoperative Adjuvant Therapy Options in Head&Neck Cancer: Concurre…

Xth Eurasian Hematology-Oncology Congress

M. Altun

37 views